# A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia

> **NCT01808326** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 5 (actual)

## Conditions studied

- Leukaemia, Lymphoblastic

## Interventions

- **DRUG:** chlorambucil, tablets

## Key facts

- **NCT ID:** NCT01808326
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2015-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01808326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01808326, "A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01808326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*